4th QTR Sales – Significant Growth Continues

The Directors of Promisia Integrative Limited (NZX:PIL) are pleased to advise that sales for the third quarter of the current financial year ending 31 December 2016 have maintained the trend set throughout 2016 year as detailed in the company's previous quarterly sales announcements. Sales for the fourth quarter were $842,576, which is a 485% increase on sales in the same quarter in 2015. Sales for the full 12 months of 2016 are $2,668,068 compared with sales of $406,644 for the same period in 2015, which is a 556% increase. The company also traded profitably for the 4th quarter of 2016, and will report the full year's annual report in due course. An independent report shows that Arthrem is currently the No.1 Single selling product in NZ Pharmacies in dollar terms. For further information please contact: Mr Stephen Underwood, Chairman on 499 3412 or 027 499 3387 Mr Charles Daily, Chief Executive Officer on 04 894 8524 or 021 643 906 ENDS End CA:00296304 For:PIL Type:QUARTER Time:2017-02-03 08:30:17